Human Megakaryocytes. V. Changes in the Phenotypic Profile of Differentiating Megakaryocytes

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1985 Mar 1

PMID 3973535

Citations 7

Authors

R B Levene

J M Lamaziere

H E Broxmeyer

L Lu

E M Rabellino

Affiliations

Soon will be listed here.

Abstract

Human megakaryocytes were studied for phenotypic changes occurring throughout differentiation using a panel of monoclonal antibodies raised against marrow megakaryocytes and blood platelets. 11 monoclonal antibody preparations were selected for restricted specificity against megakaryocytes and/or platelets after screening by immunofluorescence, complement-mediated cytolysis, and solid phase enzyme-linked immunosorbent assay. The expression of the cellular epitopes recognized by these reagents enabled the identification of three levels of megakaryocyte maturation characterized by distinct immunologic phenotypes. Based upon their reactivities against megakaryocytic cells at different ontogenetic levels, monoclonal antibodies were operationally categorized into three groups. Group A consisted of six different monoclonal antibodies that recognized antigens on the colony-forming unit-megakaryocyte (CFU-Mk), in vitro grown colony megakaryocytes, and early immature marrow megakaryocytes, only, and did not detect their respective epitopes on either mature megakaryocytes or platelets. A monoclonal antibody categorized in group B detected a cell antigen expressed by megakaryocytic cells at all maturational levels, but which is lost or suppressed during terminal differentiation and is not expressed on blood platelets. Group C included four different monoclonal antibodies raised against platelets that recognized antigenic determinants expressed on the CFU-Mk, colony megakaryocytes, early and mature megakaryocytes, and platelets. Three group C monoclonal antibodies (PC-1, PC-3, and PC-4) were specific for platelet glycoprotein IIb/IIIa. Additionally, group C monoclonal antibody PC-2 was unique in that it showed partial reactivity against the clonable progenitor for the erythroid series (BFU-E). Recognition of discrete phenotypic changes in differentiating megakaryocytes will enable multiparameter analyses of these cells as well as the study of factors regulating the dynamics of megakaryocytopoiesis in health and disease.

Citing Articles

Thrombocytopenia in mice lacking the carboxy-terminal regulatory domain of the Ets transcription factor Fli1.

Moussa O, LaRue A, Abangan Jr R, Williams C, Zhang X, Masuya M Mol Cell Biol. 2010; 30(21):5194-206.

PMID: 20823267 PMC: 2953061. DOI: 10.1128/MCB.01112-09.

Effect of increased HoxB4 on human megakaryocytic development.

Zhong Y, Sullenbarger B, Lasky L Biochem Biophys Res Commun. 2010; 398(3):377-82.

PMID: 20599537 PMC: 2921174. DOI: 10.1016/j.bbrc.2010.06.075.

Antigenic differences between human platelets and megakaryocytes.

Hyde P, Zucker-Franklin D Am J Pathol. 1987; 127(2):349-57.

PMID: 3555103 PMC: 1899752.

Phorbol ester induces c-sis gene transcription in stem cell line K-562.

Colamonici O, Trepel J, VIDAL C, Neckers L Mol Cell Biol. 1986; 6(5):1847-50.

PMID: 3466024 PMC: 367717. DOI: 10.1128/mcb.6.5.1847-1850.1986.

Induction of megakaryocytic differentiation and modulation of protein kinase gene expression by site-selective cAMP analogs in K-562 human leukemic cells.

Tortora G, Clair T, Katsaros D, Ally S, Colamonici O, Neckers L Proc Natl Acad Sci U S A. 1989; 86(8):2849-52.

PMID: 2539602 PMC: 287016. DOI: 10.1073/pnas.86.8.2849.

References

McLeod D, Shreve M, AXELRAD A . Induction of megakaryocyte colonies with platelet formation in vitro. Nature. 1976; 261(5560):492-4. DOI: 10.1038/261492a0. View

Polley M . Enhancement of hemolytic complement activity by treatment of human serum with iodine. J Immunol. 1971; 107(5):1493-5. View

EBBE S . Biology of megakaryocytes. Prog Hemost Thromb. 1976; 3:211-29. View

BRETON-GORIUS J, Guichard J . Ultrastructural localization of peroxidase activity in human platelets and megakaryocytes. Am J Pathol. 1972; 66(2):277-93. PMC: 2032483. View

Greaves M, Brown G . A human B lymphocyte specific antigen. Nat New Biol. 1973; 246(152):116-9. DOI: 10.1038/newbio246116a0. View

Aye M, Niho Y, Till J, McCulloch E . Studies of leukemic cell populations in culture. Blood. 1974; 44(2):205-19. View

Owen F, Fanger M . Studies on the human T-lymphocyte population. I. The development and characterization of a specific anti-human T-cell antibody. J Immunol. 1974; 113(4):1128-37. View

Kohler G, Milstein C . Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975; 256(5517):495-7. DOI: 10.1038/256495a0. View

Laskey R, Mills A . Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography. Eur J Biochem. 1975; 56(2):335-41. DOI: 10.1111/j.1432-1033.1975.tb02238.x. View

10.

BRETON-GORIUS J, Reyes F . Ultrastructure of human bone marrow cell maturation. Int Rev Cytol. 1976; 46:251-321. DOI: 10.1016/s0074-7696(08)60993-6. View

11.

Pfueller S, Weber S, LUSCHER E . Studies of the mechanism of the human platelet release reaction induced by immunologic stimuli. III. Relationship between the binding of soluble IgG aggregates to the Fc receptor and cell response in the presence and absence of plasma. J Immunol. 1977; 118(2):514-24. View

12.

Phillips D, Agin P . Platelet plasma membrane glycoproteins. Evidence for the presence of nonequivalent disulfide bonds using nonreduced-reduced two-dimensional gel electrophoresis. J Biol Chem. 1977; 252(6):2121-6. View

13.

Markovic O, Shulman N . Megakaryocyte maturation indicated by methanol inhibition of an acid phosphatase shared by magakaryocytes and platelets. Blood. 1977; 50(5):905-14. View

14.

Winchester R, Ross G, JAROWSKI C, Wang C, Halper J, Broxmeyer H . Expression of Ia-like antigen molecules on human granulocytes during early phases of differentiation. Proc Natl Acad Sci U S A. 1977; 74(9):4012-6. PMC: 431823. DOI: 10.1073/pnas.74.9.4012. View

15.

Rabellino E, Ross G, Trang H, Williams N, Metcalf D . Membrane receptors of mouse leukocytes. II. Sequential expression of membrane receptors and phagocytic capacity during leukocyte differentiation. J Exp Med. 1978; 147(2):434-45. PMC: 2184485. DOI: 10.1084/jem.147.2.434. View

16.

Hara H, Ogawa M . Murine hemopoietic colonies in culture containing normoblasts, macrophages, and megakaryocytes. Am J Hematol. 1978; 4(1):23-34. DOI: 10.1002/ajh.2830040105. View

17.

Jaffe E, Mosher D . Synthesis of fibronectin by cultured human endothelial cells. J Exp Med. 1978; 147(6):1779-91. PMC: 2184307. DOI: 10.1084/jem.147.6.1779. View

18.

Winchester R, Meyers P, Broxmeyer H, Wang C, Moore M, KUNKEL H . Inhibition of human erythropoietic colony formation in culture by treatment with Ia antisera. J Exp Med. 1978; 148(2):613-8. PMC: 2184943. DOI: 10.1084/jem.148.2.613. View

19.

Moore A, Ross G, Nachman R . Interaction of platelet membrane receptors with von Willebrand factor, ristocetin, and the Fc region of immunoglobulin G. J Clin Invest. 1978; 62(5):1053-60. PMC: 371865. DOI: 10.1172/JCI109210. View

20.

Markwell M, Fox C . Surface-specific iodination of membrane proteins of viruses and eucaryotic cells using 1,3,4,6-tetrachloro-3alpha,6alpha-diphenylglycoluril. Biochemistry. 1978; 17(22):4807-17. DOI: 10.1021/bi00615a031. View